CDK4/6 Inhibitors in Early-Stage HR+/HER2- Breast Cancer: Individualizing Therapeutic Decisions to Improve Patient Outcomes

Learn how global experts are leveraging the latest data on CDK4/6 inhibitors in patients with HR+/HER2- EBC. Watch the on-demand webcast from the live webinar download the slides and listen to the podcast featuring expert reviews of the most important data on early breast cancer from ESMO Breast 2021.

Share

Program Content

No activities added yet

Activities

Update: Adj Tx of HR+/HER2- EBC
Update: Adjuvant Therapy for Patients With HR+/HER2- EBC at High Risk of Recurrence
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: July 02, 2021

Expires: July 01, 2022

Update: NeoAdj Tx of HR+/HER2- EBC
Update: Debating Optimal Neoadjuvant Therapy and Future Considerations on the Horizon for HR+/HER2- EBC
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: July 02, 2021

HR+/HER2- EBC Slides
Individualizing Therapeutic Decision-Making for Patients With HR+/HER2- EBC: Downloadable Slides
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: May 12, 2021

Adj HR+/HER2- EBC Slides
Adjuvant Therapy for Patients With HR+/HER2- EBC at High Risk of Recurrence: Downloadable Slides
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: May 12, 2021

NeoAdj HR+/HER2- EBC Slides
Debating Optimal Neoadjuvant Therapy and Future Considerations on the Horizon for HR+/HER2- EBC: Downloadable Slides
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: May 12, 2021

Update: Treatment of HR+/HER2- EBC
Update: Individualizing Therapeutic Decision-Making for Patients With HR+/HER2- EBC
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: July 02, 2021

Expires: July 01, 2022

<i>EP</i>: CDK4/6i in EBC
ExpressPoints
CDK4/6 Inhibitors in Early-Stage HR+/HER2- Breast Cancer: Individualizing Therapeutic Decisions to Improve Patient Outcomes
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: July 09, 2021

Activities

Podcast Pearls: CDK4/6i in EBC
CDK4/6 Inhibitors in Early-Stage HR+/HER2- Breast Cancer: Podcast Pearls
PDF
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: August 17, 2021

Expires: August 16, 2022

Q&A: CDK4/6i in Early BC
CDK4/6 Inhibitors in Early-Stage HR+/HER2- Breast Cancer: Expert Answers to Clinician Questions
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: August 05, 2021

Expires: August 04, 2022

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

Lilly